Position in AYTU
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$319,373
-$644,527 QoQ
Shares Held
148,546
-57.9% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#6
of 38 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AYTU Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DIADEMA PARTNERS LP holds $36,596,582 across 6 Drug Manufacturers - Specialty & Generic names. AYTU ranks #5 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
52,989 | $28,711,029 | |
| 2 | BIOA |
BioAge Labs, Inc.
|
146,334 | $3,586,646 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
67,512 | $2,770,017 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
132,746 | $1,051,348 | |
| 5 | AYTU |
Aytu Biopharma, Inc
This page
|
148,546 | $319,373 | |
| 6 | TLPH |
Talphera, Inc.
|
153,563 | $158,169 |
All Filings in AYTU
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $319,373 | 148,546 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $963,900 | 353,077 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $795,048 | 305,788 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $512,619 | 272,670 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||